PortfoliosLab logoPortfoliosLab logo
MPWR vs. KNSA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MPWR vs. KNSA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Monolithic Power Systems, Inc. (MPWR) and Kiniksa Pharmaceuticals, Ltd. (KNSA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MPWR achieves a 72.87% return, which is significantly higher than KNSA's 33.60% return.


MPWR

1D
7.97%
1M
0.16%
YTD
72.87%
6M
67.48%
1Y
129.71%
3Y*
45.67%
5Y*
35.58%
10Y*
37.89%

KNSA

1D
1.66%
1M
3.51%
YTD
33.60%
6M
27.60%
1Y
93.78%
3Y*
52.43%
5Y*
29.69%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

MPWR vs. KNSA - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
MPWR
Monolithic Power Systems, Inc.
72.87%54.45%-5.55%79.78%-27.78%35.49%107.49%54.80%-10.42%
KNSA
Kiniksa Pharmaceuticals, Ltd.
33.60%108.54%12.77%17.09%27.27%-33.39%59.76%-60.63%14.89%

Correlation

The correlation between MPWR and KNSA is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.08

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.22

Correlation (All Time)
Calculated using the full available price history since May 24, 2018

0.23

The correlation between MPWR and KNSA shifts across timeframes, from 0.08 (1 year) to 0.23 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

MPWR:

$77.00B

KNSA:

$4.54B

EPS

MPWR:

$13.89

KNSA:

$0.92

PE Ratio

MPWR:

112.56

KNSA:

59.85

PEG Ratio

MPWR:

1.42

KNSA:

0.58

PS Ratio

MPWR:

25.71

KNSA:

5.80

PB Ratio

MPWR:

20.94

KNSA:

7.50

Total Revenue (TTM)

MPWR:

$2.96B

KNSA:

$754.05M

Gross Profit (TTM)

MPWR:

$1.63B

KNSA:

$294.06M

EBITDA (TTM)

MPWR:

$861.78M

KNSA:

$101.06M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MPWR vs. KNSA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MPWR
MPWR Risk / Return Rank: 9191
Overall Rank
MPWR Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
MPWR Sortino Ratio Rank: 8989
Sortino Ratio Rank
MPWR Omega Ratio Rank: 8888
Omega Ratio Rank
MPWR Calmar Ratio Rank: 9494
Calmar Ratio Rank
MPWR Martin Ratio Rank: 9393
Martin Ratio Rank

KNSA
KNSA Risk / Return Rank: 9292
Overall Rank
KNSA Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
KNSA Sortino Ratio Rank: 9191
Sortino Ratio Rank
KNSA Omega Ratio Rank: 9090
Omega Ratio Rank
KNSA Calmar Ratio Rank: 9191
Calmar Ratio Rank
KNSA Martin Ratio Rank: 9494
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MPWR vs. KNSA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Monolithic Power Systems, Inc. (MPWR) and Kiniksa Pharmaceuticals, Ltd. (KNSA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MPWRKNSADifference
Sharpe ratioReturn per unit of total volatility

+0.30

Sortino ratioReturn per unit of downside risk

-0.29

Omega ratioGain probability vs. loss probability

1.38

1.41

-0.03

Calmar ratioReturn relative to maximum drawdown

5.70

4.63

+1.07

Martin ratioReturn relative to average drawdown

15.03

16.35

-1.33

MPWR vs. KNSA - Sharpe Ratio Comparison

The current MPWR Sharpe Ratio is 2.58, which is comparable to the KNSA Sharpe Ratio of 2.27. The chart below compares the historical Sharpe Ratios of MPWR and KNSA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MPWR vs. KNSA - Drawdown Comparison

The maximum MPWR drawdown since its inception was -72.27%, smaller than the maximum KNSA drawdown of -83.06%. Use the drawdown chart below to compare losses from any high point for MPWR and KNSA.


Loading charts...

Drawdown Indicators


MPWRKNSADifference

Max Drawdown

Largest peak-to-trough decline

-72.27%

-83.06%

+10.79%

Max Drawdown (1Y)

Largest decline over 1 year

-22.45%

-21.12%

-1.33%

Max Drawdown (3Y)

Largest decline over 3 years

-51.65%

-34.14%

-17.51%

Max Drawdown (5Y)

Largest decline over 5 years

-51.65%

-53.17%

+1.52%

Max Drawdown (10Y)

Largest decline over 10 years

-51.65%

Current Drawdown

Current decline from peak

-7.47%

-7.35%

-0.12%

Average Drawdown

Average peak-to-trough decline

-17.70%

-40.60%

+22.90%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.50%

5.97%

+2.53%

Volatility

MPWR vs. KNSA - Volatility Comparison

Monolithic Power Systems, Inc. (MPWR) has a higher volatility of 23.80% compared to Kiniksa Pharmaceuticals, Ltd. (KNSA) at 10.40%. This indicates that MPWR's price experiences larger fluctuations and is considered to be riskier than KNSA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MPWRKNSADifference

Volatility (1M)

Calculated over the trailing 1-month period

23.80%

10.40%

+13.40%

Volatility (6M)

Calculated over the trailing 6-month period

39.67%

34.02%

+5.65%

Volatility (1Y)

Calculated over the trailing 1-year period

49.66%

43.03%

+6.63%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

53.86%

53.48%

+0.38%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

47.43%

63.93%

-16.50%

Dividends

MPWR vs. KNSA - Dividend Comparison

MPWR's dividend yield for the trailing twelve months is around 0.43%, while KNSA has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
KNSA
Kiniksa Pharmaceuticals, Ltd.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
MPWR
Monolithic Power Systems, Inc.
0.43%0.69%0.85%0.63%0.85%0.49%0.55%0.90%1.03%0.71%0.98%1.26%

Financials

MPWR vs. KNSA - Financials Comparison

This section allows you to compare key financial metrics between Monolithic Power Systems, Inc. and Kiniksa Pharmaceuticals, Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M20222023202420252026
804.19M
214.27M
(MPWR) Total Revenue
(KNSA) Total Revenue
Values in USD except per share items

MPWR vs. KNSA - Profitability Comparison

The chart below illustrates the profitability comparison between Monolithic Power Systems, Inc. and Kiniksa Pharmaceuticals, Ltd. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%20222023202420252026
55.3%
0
Portfolio components
MPWR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Monolithic Power Systems, Inc. reported a gross profit of 445.07M and revenue of 804.19M. Therefore, the gross margin over that period was 55.3%.

KNSA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported a gross profit of 0.00 and revenue of 214.27M. Therefore, the gross margin over that period was 0.0%.

MPWR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Monolithic Power Systems, Inc. reported an operating income of 241.15M and revenue of 804.19M, resulting in an operating margin of 30.0%.

KNSA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported an operating income of 29.27M and revenue of 214.27M, resulting in an operating margin of 13.7%.

MPWR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Monolithic Power Systems, Inc. reported a net income of 193.23M and revenue of 804.19M, resulting in a net margin of 24.0%.

KNSA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported a net income of 22.59M and revenue of 214.27M, resulting in a net margin of 10.5%.


Frequently Asked Questions


MPWR and KNSA have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MPWR has higher volatility (23.80%) compared to KNSA (10.40%). In terms of maximum drawdown, MPWR dropped -72.27% vs KNSA's -83.06%.

MPWR currently has the higher Sharpe Ratio (2.58 vs 2.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MPWR and KNSA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer